386888004: Lansoprazole (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with effector mechanism of action (substance)\Enzyme inhibitor\Hydrolase inhibitor\Proton pump inhibitor\Lansoprazole (substance)

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Gastrointestinal agent (substance)\Ulcer healing agent (substance)\Proton pump inhibitor\Lansoprazole (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Sulfur and/or sulfur compound\Sulfur compound\Organic sulfur compound\Mercaptan compound (substance)\Sulfoxide\Lansoprazole (substance)

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Pyridine and/or pyridine derivative\Pyridine\Lansoprazole (substance)

\Organic compound\Organic cyclic compound\Heterocyclic compound\Benzimidazole (substance)\Lansoprazole (substance)
\Organic compound\Organic cyclic compound\Heterocyclic compound\Pyridine and/or pyridine derivative\Pyridine\Lansoprazole (substance)
\Organic compound\Organic nitrogen compound\Pyridine and/or pyridine derivative\Pyridine\Lansoprazole (substance)
\Organic compound\Organic sulfur compound\Mercaptan compound (substance)\Sulfoxide\Lansoprazole (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

1461066015 Lansoprazole (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

1481002010 Lansoprazole en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

4497031000005119 Lansoprazol da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Lansoprazole (substance)	Is a	Proton pump inhibitor	true	Inferred relationship	Some
Lansoprazole (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Proton pump inhibitor	true	Inferred relationship	Some
Lansoprazole (substance)	Is a	kemisk stof specificeret iht. funktion	false	Inferred relationship	Some
Lansoprazole (substance)	Is a	Sulfoxide	true	Inferred relationship	Some
Lansoprazole (substance)	Is a	Pyridine	true	Inferred relationship	Some
Lansoprazole (substance)	Is a	Benzimidazole (substance)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing lansoprazole (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Lansoprazole (substance)	Inferred relationship	Some	1
Lansoprazole poisoning	Causative agent	True	Lansoprazole (substance)	Inferred relationship	Some	1
Accidental lansoprazole poisoning	Causative agent	False	Lansoprazole (substance)	Inferred relationship	Some
Intentional lansoprazole poisoning	Causative agent	False	Lansoprazole (substance)	Inferred relationship	Some
forgiftning med lansoprazol, uvist med hvilken hensigt	Causative agent	False	Lansoprazole (substance)	Inferred relationship	Some	1
Lansoprazole adverse reaction (disorder)	Causative agent	True	Lansoprazole (substance)	Inferred relationship	Some	1
Allergy to lansoprazole (finding)	Causative agent	False	Lansoprazole (substance)	Inferred relationship	Some
Lansoprazole overdose	Causative agent	True	Lansoprazole (substance)	Inferred relationship	Some	1
Accidental lansoprazole overdose	Causative agent	True	Lansoprazole (substance)	Inferred relationship	Some	1
Intentional lansoprazole overdose	Causative agent	True	Lansoprazole (substance)	Inferred relationship	Some	1
overdosis af lansoprazol, uvist med hvilken hensigt	Causative agent	False	Lansoprazole (substance)	Inferred relationship	Some	1
Product containing precisely lansoprazole 30 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Lansoprazole (substance)	Inferred relationship	Some
Product containing precisely lansoprazole 15 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Lansoprazole (substance)	Inferred relationship	Some
lansoprazol 30 mg oral suspension med modificeret udløsning	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Lansoprazole (substance)	Inferred relationship	Some
lansoprazol 15 mg suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Lansoprazole (substance)	Inferred relationship	Some
lansoprazol kapsel med modificeret udløsning a 15 mg	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Lansoprazole (substance)	Inferred relationship	Some
lansoprazol kapsel med modificeret udløsning a 30 mg	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Lansoprazole (substance)	Inferred relationship	Some
pakning med clarithromycin 500 mg tablet og lansoprazol kapsel 30 mg og amoxyllin kapsel 500 mg	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Lansoprazole (substance)	Inferred relationship	Some
Clarithromycin tablet+lansoprazole capsule+metronidazole tablet 500mg/30mg/400mg pack	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Lansoprazole (substance)	Inferred relationship	Some
lansoprazol 15 mg enterotablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Lansoprazole (substance)	Inferred relationship	Some
lansoprazol 30 mg enterotablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Lansoprazole (substance)	Inferred relationship	Some
Product containing lansoprazole and naproxen (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Lansoprazole (substance)	Inferred relationship	Some	2
lansoprazol 15 mg kapsel med modificeret udløsning + naproxen 375 mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Lansoprazole (substance)	Inferred relationship	Some
lansoprazol 15 mg kapsel med modificeret udløsning + naproxen 500 mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Lansoprazole (substance)	Inferred relationship	Some
lansoprazol oralt opløselig 30 mg kapsel	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Lansoprazole (substance)	Inferred relationship	Some
lansoprazol oralt opløselig 15 mg kapsel	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Lansoprazole (substance)	Inferred relationship	Some
lansoprazol 15 mg enterotablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Lansoprazole (substance)	Inferred relationship	Some
lansoprazol 30 mg enterotablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Lansoprazole (substance)	Inferred relationship	Some
Accidental lansoprazole poisoning	Causative agent	True	Lansoprazole (substance)	Inferred relationship	Some	1
Intentional lansoprazole poisoning	Causative agent	True	Lansoprazole (substance)	Inferred relationship	Some	1
pakning med clarithromycin 500 mg tablet + lansoprazol 30 mg kapsel + metronidazol 400 mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Lansoprazole (substance)	Inferred relationship	Some
lansoprazol 15 mg kapsel med modificeret udløsning + naproxen 250 mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Lansoprazole (substance)	Inferred relationship	Some
Product containing precisely lansoprazole 30 milligram/1 vial powder for conventional release solution for injection (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Lansoprazole (substance)	Inferred relationship	Some
Product containing lansoprazole in parenteral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Lansoprazole (substance)	Inferred relationship	Some	1
Lansoprazole-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Lansoprazole (substance)	Inferred relationship	Some	1
Allergy to lansoprazole (finding)	Causative agent	True	Lansoprazole (substance)	Inferred relationship	Some	1
Product containing precisely lansoprazole 30 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Lansoprazole (substance)	Inferred relationship	Some	1
Product containing precisely lansoprazole 30 milligram/1 each conventional release oral capsule (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Lansoprazole (substance)	Inferred relationship	Some	1
Product containing precisely lansoprazole 15 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Lansoprazole (substance)	Inferred relationship	Some	1
Product containing precisely lansoprazole 15 milligram/1 each conventional release oral capsule (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Lansoprazole (substance)	Inferred relationship	Some	1
Product containing precisely lansoprazole 30 milligram/1 each gastro-resistant oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Lansoprazole (substance)	Inferred relationship	Some
Product containing precisely lansoprazole 15 milligram/1 each gastro-resistant oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Lansoprazole (substance)	Inferred relationship	Some
Product containing precisely lansoprazole 30 milligram/1 each conventional release oral capsule (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Lansoprazole (substance)	Inferred relationship	Some	1
Product containing precisely lansoprazole 15 milligram/1 each conventional release oral capsule (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Lansoprazole (substance)	Inferred relationship	Some	1
Lansoprazole 30 mg granules for gastro-resistant oral suspension sachet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Lansoprazole (substance)	Inferred relationship	Some	1
Lansoprazole 30 mg granules for gastro-resistant oral suspension sachet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Lansoprazole (substance)	Inferred relationship	Some	1
Product containing only lansoprazole and naproxen (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Lansoprazole (substance)	Inferred relationship	Some	2
Product containing only lansoprazole (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Lansoprazole (substance)	Inferred relationship	Some	1
Product containing only lansoprazole in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Lansoprazole (substance)	Inferred relationship	Some	1
Lansoprazole only product in parenteral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Lansoprazole (substance)	Inferred relationship	Some	1
Product containing precisely lansoprazole 30 milligram/1 each gastro-resistant oral capsule (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Lansoprazole (substance)	Inferred relationship	Some	1
Product containing precisely lansoprazole 30 milligram/1 each gastro-resistant oral capsule (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Lansoprazole (substance)	Inferred relationship	Some	1
Product containing precisely lansoprazole 15 milligram/1 each gastro-resistant oral capsule (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Lansoprazole (substance)	Inferred relationship	Some	1
Product containing precisely lansoprazole 15 milligram/1 each gastro-resistant oral capsule (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Lansoprazole (substance)	Inferred relationship	Some	1
Lansoprazole 15 mg orodispersible tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Lansoprazole (substance)	Inferred relationship	Some	1
Lansoprazole 15 mg orodispersible tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Lansoprazole (substance)	Inferred relationship	Some	1
Lansoprazole 30 mg orodispersible tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Lansoprazole (substance)	Inferred relationship	Some	1
Lansoprazole 30 mg orodispersible tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Lansoprazole (substance)	Inferred relationship	Some	1
Product containing precisely lansoprazole 30 milligram/1 vial powder for conventional release solution for injection (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Lansoprazole (substance)	Inferred relationship	Some	1
Product containing precisely lansoprazole 30 milligram/1 vial powder for conventional release solution for injection (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Lansoprazole (substance)	Inferred relationship	Some	1
Product containing only lansoprazole in oromucosal dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Lansoprazole (substance)	Inferred relationship	Some	1
Product containing lansoprazole in oromucosal dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Lansoprazole (substance)	Inferred relationship	Some	1

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1461066015	Lansoprazole (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1481002010	Lansoprazole	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
4497031000005119	Lansoprazol	da	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	Danish module (core metadata concept)